Table 3 Univariate Cox analysis of the relationship between H2AFY expression and overall survival among hepatocellular carcinoma patients
From: The diagnostic and prognostic value of H2AFY in hepatocellular carcinoma
Clinical characteristic | HR | %95CI | p-value |
|---|---|---|---|
H2AFY | 2.298 | 1.533–3.443 | 5.492e-05 |
Clinical stage | 1.864 | 1.455–2.388 | 8.066e-07 |
T stage | 1.804 | 1.455–2.270 | 4.725e-07 |
M stage | 3.850 | 1.206–12.281 | 0.022 |
N stage | 2.021 | 0.493–8.276 | 0.327 |
G stage | 1.017 | 0.745–1.387 | 0.914 |
Sex | 0.780 | 0.487–1.249 | 0.301 |
Age | 1.005 | 0.986–1.023 | 0.591 |